Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
Open accessThe DOI matches its Crossref record.
Abstract
Transiliac biopsies from 34 female patients with corticosteroid treated chronic active hepatitis have been examined to determine the contributions made by decreased bone formation and increased bone resorption to bone loss associated with this condition and to determine the structural basis of the bone loss. Mean wall thickness was significantly reduced when compared with control values (p less than 0.001) as was the bone formation rate at tissue (p less than 0.005) and basic multicellular unit (p less than 0.005) level. The osteoid maturation period and the bone formation period were significantly prolonged (p less than 0.02 and 0.05). The total resorption surfaces were significantly increased (p less than 0.02) but the mean interstitial bone thickness was normal. The mean trabecular plate thickness was significantly reduced (p less than 0.005). These findings indicate that decreased bone formation plays a major role in bone loss associated with corticosteroid treated chronic active hepatitis and that the structural basis of bone loss is trabecular thinning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis
Dr. Dempster, D. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040202 · Cited by 319
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
Eastell, R., Reid, D. M., Compston, J., Cooper, C., Fogelman, I., Francis, R. M., Hosking, D. J., Purdie, D. W., Ralston, S. H., Reeve, J., et al. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00408.x · Cited by 315
Self-citationWeinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Gallego-Rojo, F. J., Gonzalez-Calvin, J. L., Muñoz-Torres, M., Mundi, J. L., Fernandez-Perez, R., & Rodrigo-Moreno, D. (1998) · Hepatology · doi:10.1002/hep.510280315 · Cited by 241
Schiefke, I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1843 · Cited by 156
Rouillard, S., & Lane, N. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20533 · Cited by 125
Ninkovic, M., Love, S. A., Tom, B., Alexander, G. J. M., & Compston, J. E. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-2028-4 · Cited by 123
“In addition, direct detrimental effects of alcohol [28], iron [29], and corticosteroids in patients with autoimmune liver disease [30] have been implicated.”
BackgroundMechanism of bone loss after liver transplantation: A histomorphometric analysis
Vedi, S., Greer, S., Skingle, S. J., Garrahan, N. J., Ninkovic, M., Alexander, G. A., & Dr. Compston, J. E. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.2.281 · Cited by 74
Osteoporosis in liver diseases and after liver transplantation
Hay, J. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00143-0 · Cited by 72
“Significant osteoporosis is reported in autoimmune hepatitis, hemochromatosis and alcoholic cirrhosis ([16], #386, [32], #369, [39], #56).”
BackgroundOsteoprotegerin and RANKL in alcoholic liver cirrhosis
Fábrega, E., Orive, A., García‐Suarez, C., García‐Unzueta, M., Antonio Amado, J., & Pons‐Romero, F. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01073.x · Cited by 48
Does iron affect osteoblast function? StudiesIn vitro and in patients with chronic liver disease
Diamond, T., Pojer, R., Stiel, D., Alfrey, A., & Posen, S. (1991) · Calcified Tissue International · doi:10.1007/bf02556449 · Cited by 44
Metadata
- Authors
- Stellon, A. J., Webb, A., & Compston, J. E.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1988-03
- Volume
- 29
- Issue
- 3
- Pages
- 378-384
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2118534072
- Cited by
- 86
- References
- 0
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.